Ahn, C. (1998). An evaluation of phase I cancer clinical trial designs. Statistics in Medicine17, 1537-1549.
Aranda-Ordaz, F.J. (1981). On two families of transformations to additivity for binary response data. Biometrika68, 357-363.
Atkinson, A. C. and Donev, A. N. (2001). Optimum Experimental Designs. New York:Oxford University Press.
Babb, J. S. and Rogatko, A. (2001). Patient speci.c dosing in a cancer phase I clinical trial. Statistics in Medicine20, 2079-2090.
Babb, J., Rogatko, A., and Zacks, S. (1998). Cancer phase I clinical trials: efficient dose escalation with overdose control. Statistics in Medicine17, 1103-1120.